Cargando…
Identification of Potential Leishmania N-Myristoyltransferase Inhibitors from Withania somnifera (L.) Dunal: A Molecular Docking and Molecular Dynamics Investigation
Leishmaniasis is a group of infectious diseases caused by Leishmania protozoa. The ineffectiveness, high toxicity, and/or parasite resistance of the currently available antileishmanial drugs has created an urgent need for safe and effective leishmaniasis treatment. Currently, the molecular-docking t...
Autores principales: | Orabi, Mohamed A. A., Alshahrani, Mohammed Merae, Sayed, Ahmed M., Abouelela, Mohamed E., Shaaban, Khaled A., Abdel-Sattar, El-Shaymaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861338/ https://www.ncbi.nlm.nih.gov/pubmed/36677018 http://dx.doi.org/10.3390/metabo13010093 |
Ejemplares similares
-
An updated review on phytochemistry and molecular targets of Withania somnifera (L.) Dunal (Ashwagandha)
por: Bashir, Arsalan, et al.
Publicado: (2023) -
The immunomodulatory role of withania somnifera (L.) dunal in inflammatory diseases
por: Alanazi, Hamad H., et al.
Publicado: (2023) -
Influence of lunar cycles on growth of Ashwagandha (Withania somnifera [L.] Dunal)
por: Tavhare, Swagata D., et al.
Publicado: (2015) -
Efficacy of Ashwagandha (Withania somnifera Dunal. Linn.) in the management of psychogenic erectile dysfunction
por: Mamidi, Prasad, et al.
Publicado: (2011) -
Penicillium setosum, a new species from Withania somnifera (L.) Dunal
por: George, Tijith K., et al.
Publicado: (2018)